Future of AI in Regulatory and Good Manufacturing Practice (GMP) in Pharma, Biotech, and Medical Device Industries

Description

Artificial Intelligence (AI) is transforming regulatory compliance and Good Manufacturing Practice (GMP) in the pharmaceutical, biotechnology, and medical device industries. AI technologies such as regulatory intelligence, predictive analytics, and automation are improving compliance efficiency, quality management, and decision-making. However, global regulatory agencies are still defining how AI fits within GMP frameworks.

This webinar will cover:

• Current and future regulatory frameworks for AI-driven compliance and quality management
• Key AI applications in pharma, biotech, and medical device manufacturing
• Challenges in AI validation, regulatory submissions, and AI-based decision-making
• Real-world case studies of AI implementation in GMP environments

By the end of this session, attendees will:

• Understand how AI is reshaping regulatory compliance and GMP in the life sciences sector
• Learn to implement AI responsibly within existing regulatory frameworks
• Gain insights into global regulatory expectations from agencies such as the FDA, EMA, and MHRA

Areas Covered in the Session:-

• AI-driven automation in GMP compliance
• How AI accelerates regulatory submissions
• AI in pharmacovigilance and post-market surveillance
• Predictive analytics for GMP manufacturing and process optimization
• Ensuring AI-driven data integrity and audit readiness
• Regulatory challenges and best practices for AI validation
• Case studies on AI in pharma, biotech, and medical device compliance.

Background

AI is revolutionizing how regulatory compliance, quality assurance, and GMP practices are managed in life sciences. As regulatory bodies like the FDA, EMA, MHRA, and PMDA update their frameworks, AI is emerging as a key enabler for automating compliance, ensuring data integrity, strengthening quality systems, and improving manufacturing processes.

Led by Dr. David Lim, Ph.D., this webinar will explore how AI is transforming regulatory affairs, GMP compliance, and Quality Management Systems (QMS). Attendees will also gain insights into overcoming challenges in AI validation, understanding regulatory expectations, and developing practical implementation strategies.

Why Should You Attend?

With increasing regulatory scrutiny and outdated manual processes, companies face growing challenges in maintaining compliance. AI offers powerful solutions to streamline and modernize quality and regulatory operations.

You will learn how AI can:

• Automate batch record reviews, CAPA investigations, and regulatory submissions
• Strengthen risk-based QMS, audit readiness, and post-market surveillance
• Predict and prevent manufacturing deviations using advanced analytics
• Ensure real-time compliance and data integrity through AI-driven monitoring

However, improper AI implementation can lead to compliance risks, FDA warnings, and costly rejections. This session will help you understand how to deploy AI effectively and compliantly—minimizing risk while maximizing efficiency.

Who Will Benefit?

This session is designed for professionals in:

• Regulatory Affairs and Compliance
• Quality Assurance (QA) and Quality Control (QC)
• GMP and GxP Compliance
• Pharmaceutical and Biotech Manufacturing
• Medical Device Quality and Validation
• AI, Digital Health, and Data Science in Regulatory Affairs.